スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
65 Hits
検索条件 : 絞込み (MeSH = Drug Resistance, Neoplasm / genetics*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
MOLT-4(RCB0206)
,
SKW-3(RCB1168)
77504
Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
Cancer Chemother Pharmacol
2022-1-1
Pubmed
Full text
ヒト・動物細胞
HL60(RCB0041)
77166
Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin.
Leuk Lymphoma
2012-7-1
Pubmed
Full text
ヒト・動物細胞
U-87 MG(RCB0419)
72921
Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cells.
Int J Cancer
1998-7-3
Pubmed
Full text
ヒト・動物細胞
HuH-7(RCB1366)
72236
The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.
Cancer Sci
2021-9-1
Pubmed
Full text
ヒト・動物細胞
Ba/F3(RCB0805)
70021
Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.
Cancer Sci
2022-3-1
Pubmed
Full text
ヒト・動物細胞
293T(RCB2202)
69513
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
Cancer Sci
2021-12-1
Pubmed
Full text
ヒト・動物細胞
Ba/F3(RCB0805)
69464
Clinical Acquired Resistance to KRAS
G12C
Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Cancer Discov
2021-8-1
Pubmed
Full text
ヒト・動物細胞
A549(RCB0098)
69025
Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells.
Oncol Rep
2022-2-1
Pubmed
Full text
ヒト・動物細胞
Ba/F3
68843
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.
Clin Cancer Res
2014-11-15
Pubmed
Full text
ヒト・動物細胞
MG-63(RCB1890)
68123
Ca
2+
-activated K
+
channel K
Ca
1.1 as a therapeutic target to overcome chemoresistance in three-dimensional sarcoma spheroid models.
Cancer Sci
2021-9-1
Pubmed
Full text
ヒト・動物細胞
DT40(RCB1464)
67556
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.
Blood
2015-7-2
Pubmed
Full text
ヒト・動物細胞
Ba/F3(RCB0805)
67548
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.
Nat Med
2015-1-1
Pubmed
Full text
ヒト・動物細胞
A549(RCB0098)
,
LC-2/ad(RCB0440)
67405
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Mol Cancer Ther
2015-11-1
Pubmed
Full text
ヒト・動物細胞
RPMI8226(RCB3010)
67310
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.
J Cell Physiol
2018-5-1
Pubmed
Full text
ヒト・動物細胞
HuCCT1(RCB1960)
,
RBE(RCB1292)
,
SSP-25(RCB1293)
,
HuH-28(RCB1943)
66894
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Cancer Discov
2019-8-1
Pubmed
Full text
ヒト・動物細胞
Ba/F3
66042
Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers.
Mol Cancer Ther
2017-10-1
Pubmed
Full text
ヒト・動物細胞
MIA Paca2(RCB2094)
65976
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
J Pharmacol Sci
2015-3-1
Pubmed
Full text
ヒト・動物細胞
TFK-1(RCB2537)
,
HuCCT1(RCB1960)
65877
Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Oncotarget
2017-6-27
Pubmed
Full text
ヒト・動物細胞
Ba/F3
65869
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.
Mol Cancer Ther
2017-2-1
Pubmed
Full text
ヒト・動物細胞
MRC-5(RCB0218)
65828
MET
Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of
EGFR
-mutant Lung Cancer.
Mol Cancer Ther
2017-3-1
Pubmed
Full text